Suchergebnisse - "Zhong, Nanshan"

PubPharm (22)

1

Tiotropium reduces clinically important deterioration in patients with mild-to-moderate chronic obstructive pulmonary disease : A post hoc analysis of the Tie-COPD study

enthalten in: Respiratory medicine | 2024

von Wu, F. | Dai, C. | Zhou, Y. | +7

2

Single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD : subgroup analysis of the China cohort in the IMPACT trial

enthalten in: Current medical research and opinion | 2021

von Zheng, J. | Zhong, N. | Wang, C. | +9

3

Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD

enthalten in: International journal of chronic obstructive pulmonary disease | 2020

von Chen, R. | Zhong, N. | Wang, H. | +9

4

Efficacy and Safety of Once-Daily Inhaled Umeclidinium in Asian Patients with COPD : Results from a Randomized, Placebo-Controlled Study

enthalten in: International journal of chronic obstructive pulmonary disease | 2020

von Zhong, N. | Zheng, J. | Lee, S. | +3

5

The Efficacy and Safety of Once-daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-daily Budesonide/Formoterol in a Subgroup of Patients from China with Symptomatic COPD at Risk of Exacerbations (FULFIL Trial)

enthalten in: COPD | 2018

von Zheng, J. | Zhong, N. | Wang, C. | +10

6

As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma

enthalten in: The New England journal of medicine | 2018

von Bateman, E. | Reddel, H. | O'Byrne, P. | +7

CommentIn: N Engl J Med. 2018 May 17;378(20):1940-1942. - PMID 29768146

7

Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma

enthalten in: The New England journal of medicine | 2018

von O'Byrne, P. | FitzGerald, J. | Bateman, E. | +7

CommentIn: N Engl J Med. 2018 May 17;378(20):1940-1942. - PMID 29768146

8

Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD : a randomized Phase III study conducted in Asia, Europe, and the USA

enthalten in: International journal of chronic obstructive pulmonary disease | 2018

von Lipworth, B. | Collier, D. | Gon, Y. | +8

9

Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations : a post hoc analysis of the GOAL study

enthalten in: BMC pulmonary medicine | 2017

von Bousquet, J. | Barnes, N. | Gibbs, M. | +7

10

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations : results from the FLAME study

enthalten in: International journal of chronic obstructive pulmonary disease | 2017

von Wedzicha, J. | Zhong, N. | Ichinose, M. | +5